Familial lipoatrophic diabetes with dominant transmission. A new syndrome.
D000328:Adult; D002747:Chlorpropamide / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000235:genetics*; D004040:Dietary Carbohydrates / Q000627:therapeutic use; D005260:Female; D005799:Genes, Dominant; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy / Q000235:genetics; D007328:Insulin / Q000097:blood; D008060:Lipodystrophy / Q000188:drug therapy / Q000235:genetics* / Q000628:therapy; D008074:Lipoproteins / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008875:Middle Aged; D010375:Pedigree; D010629:Phenformin / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D004040:Dietary Carbohydrates; D007328:Insulin; D008074:Lipoproteins; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D014280:Triglycerides; D002784:Cholesterol; D010629:Phenformin; D002994:Clofibrate; D002747:Chlorpropamide